Clinical trials data
Trail Making Test in mild cognitive impairment trials: 213 registered studies
Every registered mild cognitive impairment study on ClinicalTrials.gov that names the Trail Making Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered mild cognitive impairment studies name it in an outcome measure
- 213
- Name it in a primary outcome, 38%
- 82 of 213
Tests named in the same studies
- 1
Digit Span Test95 studies, 34 as a primary outcome
- 2
Verbal Fluency86 studies, 28 as a primary outcome
- 3
Verbal Learning84 studies, 44 as a primary outcome
- 4
Stroop Color-Word Test64 studies, 22 as a primary outcome
- 5
Category Fluency51 studies, 23 as a primary outcome
- 6
Symbol Coding42 studies, 22 as a primary outcome
- 7
Picture Naming Test41 studies, 11 as a primary outcome
- 8
Short Story Recall29 studies, 14 as a primary outcome
- 9
Complex Figure Copy and Recall22 studies, 9 as a primary outcome
- 10
Clock Drawing Task21 studies, 8 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 1 |
| 2010 | 5 | 3 |
| 2011 | 4 | 1 |
| 2012 | 5 | 1 |
| 2013 | 2 | 0 |
| 2014 | 2 | 1 |
| 2015 | 6 | 2 |
| 2016 | 11 | 3 |
| 2017 | 9 | 4 |
| 2018 | 6 | 4 |
| 2019 | 13 | 5 |
| 2020 | 18 | 8 |
| 2021 | 19 | 9 |
| 2022 | 16 | 5 |
| 2023 | 26 | 7 |
| 2024 | 23 | 14 |
| 2025 | 22 | 5 |
| 2026 | 23 | 8 |
Phases and study sizes
By phase
- Early phase 14 studies, 2 as a primary outcome
- Phase 11 studies, 0 as a primary outcome
- Phase 220 studies, 7 as a primary outcome
- Phase 2/31 studies, 0 as a primary outcome
- Phase 32 studies, 1 as a primary outcome
- Phase 45 studies, 1 as a primary outcome
- Not applicable165 studies, 67 as a primary outcome
- Observational15 studies, 4 as a primary outcome
Participants per study
- Phase 278 median, 54 to 142
- Not applicable62 median, 38 to 128
- Observational140 median, 80 to 425
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 19 | 78 | 54 to 142 |
| Not applicable | 165 | 62 | 38 to 128 |
| Observational | 15 | 140 | 80 to 425 |
When mild cognitive impairment trials measure it
Latest time point of each outcome
- Within a day11 outcomes, 5 as a primary outcome
- Up to 4 weeks17 outcomes, 4 as a primary outcome
- 1 to 3 months57 outcomes, 31 as a primary outcome
- 3 to 6 months44 outcomes, 16 as a primary outcome
- 6 to 12 months43 outcomes, 9 as a primary outcome
- 1 to 2 years18 outcomes, 9 as a primary outcome
- Over 2 years9 outcomes, 1 as a primary outcome
- No duration given14 outcomes, 7 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
199 of the 213 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting48 studies, 18 as a primary outcome
- Not yet recruiting15 studies, 3 as a primary outcome
- Active, not recruiting6 studies, 4 as a primary outcome
- Completed98 studies, 39 as a primary outcome
- Stopped early5 studies, 2 as a primary outcome
- Status unknown41 studies, 16 as a primary outcome
What they test
- Behavioral78 studies, 34 as a primary outcome
- Drug27 studies, 9 as a primary outcome
- Device46 studies, 10 as a primary outcome
- Dietary supplement15 studies, 4 as a primary outcome
- Procedure6 studies, 1 as a primary outcome
- Diagnostic test3 studies, 2 as a primary outcome
- Biological2 studies, 0 as a primary outcome
- Radiation1 studies, 0 as a primary outcome
- Combination product4 studies, 2 as a primary outcome
- Other63 studies, 30 as a primary outcome
- None given9 studies, 3 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States70 studies, 25 as a primary outcome
- Italy24 studies, 2 as a primary outcome
- Canada13 studies, 3 as a primary outcome
- China12 studies, 3 as a primary outcome
- Hong Kong11 studies, 4 as a primary outcome
- Spain10 studies, 5 as a primary outcome
- France7 studies, 2 as a primary outcome
- Germany7 studies, 2 as a primary outcome
- South Korea7 studies, 4 as a primary outcome
- Greece6 studies, 5 as a primary outcome
- Pakistan6 studies, 5 as a primary outcome
- Switzerland6 studies, 0 as a primary outcome
35 countries in all. A study with sites in several counts in each; 11 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed mild cognitive impairment studies that name the Trail Making Test: 46 of 98, 47%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed mild cognitive impairment studies that name the Trail Making Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 16, 16% | 776, 10% |
| Results on ClinicalTrials.gov only | 12, 12% | 1,139, 14% |
| A results paper only | 18, 18% | 1,711, 22% |
| Neither | 52, 53% | 4,327, 54% |
The 213 studies
213 studies match. 82 name the Trail Making Test in a primary outcome. Median size 70 participants. Median time to the primary outcome: 13 weeks.
Loading 213 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 1 |
| 2010 | 5 | 3 |
| 2011 | 4 | 1 |
| 2012 | 5 | 1 |
| 2013 | 2 | 0 |
| 2014 | 2 | 1 |
| 2015 | 6 | 2 |
| 2016 | 11 | 3 |
| 2017 | 9 | 4 |
| 2018 | 6 | 4 |
| 2019 | 13 | 5 |
| 2020 | 18 | 8 |
| 2021 | 19 | 9 |
| 2022 | 16 | 5 |
| 2023 | 26 | 7 |
| 2024 | 23 | 14 |
| 2025 | 22 | 5 |
| 2026 | 23 | 8 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 17, other 196. Interventional 198, observational 15.
As a primary outcomeSecondary or other outcomeThe Trail Making Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07883148 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants52 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07865260 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Stroke, Parkinson's disease | Participants80 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07856043 | Start2026 | PhasePhase 1 | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Cardiovascular disease | Participants18 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07775079 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants96 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07764250 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants96 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07735910 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Depression and bipolar disorder, Sleep and sleep disorders, Anxiety, PTSD and OCD | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07733726 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise | Participants66 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07731334 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants384 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07667478 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07652775 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Depression and bipolar disorder | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07646054 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants1,200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07642518 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Obesity and diabetes | Participants38 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07636538 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Stroke, Parkinson's disease | Participants30 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07629349 | Start2020 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants600 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07616050 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Stroke, Parkinson's disease, Multiple sclerosis, Aging, frailty and exercise | Participants70 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07598409 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment, Healthy volunteers, Aging, frailty and exercise | Participants156 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07547111 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants42 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07517380 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07512193 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants10 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07497334 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07423260 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants38 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07402356 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Depression and bipolar disorder | Participants140 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07385937 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07376135 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants300 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07366346 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
Questions, answered from the data
How many mild cognitive impairment trials use the Trail Making Test?
213 registered mild cognitive impairment studies on ClinicalTrials.gov name it in an outcome measure, 82 of them in a primary outcome: 25% of the condition's 859 studies with a cognitive outcome, against 14% of all of them. It is the test mild cognitive impairment trials name most.
Which tests do mild cognitive impairment trials use with the Trail Making Test?
The Digit Span Test (95 studies), Verbal Fluency (86 studies) and Verbal Learning (84 studies).
How many participants do phase 2 mild cognitive impairment trials that use the Trail Making Test enroll?
Half of the phase 2 studies that name it enroll 78 participants or fewer, and the middle half enroll 54 to 142. 19 of them give a size.
When do mild cognitive impairment trials measure the Trail Making Test?
Half of the primary outcomes that name the Trail Making Test are measured within 13 weeks of the start, and the middle half from 8 weeks to 7 months. 75 primary outcomes give a duration.
How many completed mild cognitive impairment trials that use the Trail Making Test have reported results?
46 of the 98 completed studies that name it, 47%, have reported results: 28 posted them on ClinicalTrials.gov, 34 have a results paper linked to the registry record, and 16 did both. The other 52 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Trail Making Test A and Trail Making Test B as one test family, so this page counts their studies together.
Run the Trail Making Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.